Kennedy John Jed's Form 4 filing
CONMED Corp (CNMD) · filed Aug 31, 2021
- Accession no.
- 0001127602-21-024594
- Filed
- Aug 31, 2021
- Trade date
- Aug 30, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $571.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kennedy John JedCIK 0001287981 | Officer (Group Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2021 | Common Stock | MOption exerciseAcquired | +3,640 | $41.93 | +$152,625.2 | 11,015 | Direct | |
| Aug 30, 2021 | Common Stock | SSaleDisposed | −3,640 | $134.75F1 | −$490,490 | 7,375 | Direct | |
| Aug 30, 2021 | Common Stock | MOption exerciseAcquired | +300 | $59.96 | +$17,988 | 7,675 | Direct | |
| Aug 30, 2021 | Common Stock | SSaleDisposed | −300 | $134.75 | −$40,425 | 7,375 | Direct | |
| Aug 30, 2021 | Common Stock | MOption exerciseAcquired | +100 | $78.76 | +$7,876 | 7,475 | Direct | |
| Aug 30, 2021 | Common Stock | SSaleDisposed | −100 | $134.75 | −$13,475 | 7,375 | Direct | |
| Aug 30, 2021 | Common Stock | MOption exerciseAcquired | +200 | $97.69 | +$19,538 | 7,575 | Direct | |
| Aug 30, 2021 | Common Stock | SSaleDisposed | −200 | $134.75 | −$26,950 | 7,375 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2021 | Common Stock | MOption exerciseDisposed | −3,640 | $0.00 | $0 | 5,862 | Direct | |
| Aug 30, 2021 | Common Stock | MOption exerciseDisposed | −300 | $0.00 | $0 | 15,900 | Direct | |
| Aug 30, 2021 | Common Stock | MOption exerciseDisposed | −100 | $0.00 | $0 | 7,500 | Direct | |
| Aug 30, 2021 | Common Stock | MOption exerciseDisposed | −200 | $0.00 | $0 | 9,300 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $134.79. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Referenced by the price of 1 transaction in Table I.